Odonate Therapeutics, Inc. Proceeds from Stock Plans
Odonate Therapeutics, Inc. reported Proceeds from Stock Plans of $825.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2021-11-10
- Odonate Therapeutics, Inc. proceeds from stock plans for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Odonate Therapeutics, Inc. proceeds from stock plans for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Odonate Therapeutics, Inc. proceeds from stock plans for the quarter ending 2021-03-31 was $825.00K, a 58.35% increase year-over-year.
- Odonate Therapeutics, Inc. proceeds from stock plans for the quarter ending 2020-12-31 was $525.00K, a 56.25% decline year-over-year.
- Odonate Therapeutics, Inc. proceeds from stock plans for fiscal 2020 was $2.98M, a 16.67% decline from fiscal 2019.
- Odonate Therapeutics, Inc. proceeds from stock plans for fiscal 2019 was $3.58M, a 926.07% increase from fiscal 2018.
- Odonate Therapeutics, Inc. proceeds from stock plans for fiscal 2018 was $349.00K.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $825.00K 10-Q · filed 2021-11-10 | $1.35M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $825.00K 10-Q · filed 2021-07-27 | $1.35M derived: sum of 3 quarters · filed 2021-07-27 | $2.15M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $825.00K 10-Q · filed 2021-05-14 | $1.35M derived: sum of 2 quarters · filed 2021-05-14 | $2.15M derived: sum of 3 quarters · filed 2021-11-10 | $3.29M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $1.33M derived: sum of 2 quarters · filed 2021-11-10 | $2.46M derived: sum of 3 quarters · filed 2021-11-10 | $2.98M 10-K · filed 2021-02-23 |
| 2020-09-30 | $805.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.94M derived: sum of 2 quarters · filed 2021-11-10 | $2.46M 10-Q · filed 2021-11-10 | $3.66M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $1.65M 10-Q · filed 2021-07-27 | $2.85M derived: sum of 3 quarters · filed 2021-07-27 | $4.65M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $521.00K 10-Q · filed 2021-05-14 | $1.72M derived: sum of 2 quarters · filed 2021-05-14 | $3.52M derived: sum of 3 quarters · filed 2021-05-14 | $3.94M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $3.00M derived: sum of 2 quarters · filed 2021-02-23 | $3.42M derived: sum of 3 quarters · filed 2021-02-23 | $3.58M 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $2.22M derived: sum of 2 quarters · filed 2020-10-28 | $2.38M 10-Q · filed 2020-10-28 | $2.52M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | $427.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $586.00K 10-Q · filed 2020-07-30 | $730.00K derived: sum of 3 quarters · filed 2020-07-30 | $837.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $159.00K 10-Q · filed 2020-04-28 | $303.00K derived: sum of 2 quarters · filed 2020-04-28 | $410.00K derived: sum of 3 quarters · filed 2020-04-28 | |
| 2018-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $251.00K derived: sum of 2 quarters · filed 2020-02-20 | $349.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $205.00K 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $98.00K 10-Q · filed 2019-07-24 |